Archive: 2026/03

FDA Listing for Biosimilars: How They Are Evaluated and Approved

22Mar
FDA Listing for Biosimilars: How They Are Evaluated and Approved

The FDA doesn't rate biosimilars like generics - it uses a rigorous science-based process to approve them. Learn how biosimilars are evaluated, listed in the Purple Book, and why they're not interchangeable by default.

More

Opioids and Liver Disease: How Liver Damage Changes Pain Medication Risks

18Mar
Opioids and Liver Disease: How Liver Damage Changes Pain Medication Risks

Liver disease changes how opioids are processed, leading to dangerous buildup and side effects. Morphine and oxycodone become riskier, with half-lives extending dramatically. Dosing must be adjusted carefully to avoid toxicity.

More

OTC Medication Safety During Pregnancy: What to Ask First

17Mar
OTC Medication Safety During Pregnancy: What to Ask First

Learn the five essential questions to ask before taking any OTC medication during pregnancy. Get clear, current guidance on what's safe, what to avoid, and how to protect your baby’s health.

More

Weight Gain from Antidepressants: Which Drugs Cause It and How to Manage It

15Mar
Weight Gain from Antidepressants: Which Drugs Cause It and How to Manage It

Weight gain is a common side effect of many antidepressants, affecting over half of long-term users. Learn which drugs are most likely to cause it, why it happens, and how to manage it without quitting treatment.

More

Generic Drug Approval Standards: Safety, Quality, and Strength Requirements

11Mar
Generic Drug Approval Standards: Safety, Quality, and Strength Requirements

Generic drugs must meet the same safety, quality, and strength standards as brand-name drugs under FDA regulations. Learn how bioequivalence testing, cGMP compliance, and complex product requirements ensure generics work just as well.

More

Insurer Pressure: How Providers Respond to Generic Drug Substitution Requirements

8Mar
Insurer Pressure: How Providers Respond to Generic Drug Substitution Requirements

Insurers are forcing providers to switch patients to generic drugs through strict formulary rules, prior authorization, and step therapy. While it saves money, it’s creating delays, administrative chaos, and clinical risks - with patients paying the price.

More

Antidotes for Common Medication Overdoses: What You Need to Know

4Mar
Antidotes for Common Medication Overdoses: What You Need to Know

Learn how common antidotes like naloxone and NAC reverse life-threatening overdoses. This practical guide explains when, how, and why these treatments work-and what you should do if someone overdoses.

More

Rheumatoid Arthritis: How Biologic DMARDs Can Lead to Disease Remission

3Mar
Rheumatoid Arthritis: How Biologic DMARDs Can Lead to Disease Remission

Biologic DMARDs have transformed rheumatoid arthritis treatment, offering real disease remission for many patients. Learn how they work, which ones are most effective, and what to expect in terms of results, risks, and costs.

More